Amylyx Will Submit ALS Drug For Approval In The Coming Months

Continues ‘As Fast As Possible’ Approach With AMX0035

 
• By Mandy Jackson
  
Physiotherapist assisting a patient with Amyotrophic Lateral Sclerosis
AMX0035 slowed disease progression in CENTAUR as assessed by an ALS functional rating scale • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip